AOD-9604 is a synthetic peptide derived from the C-terminal fragment (amino acids 177–191) of human growth hormone (hGH), specifically designed to mimic the lipolytic (fat-burning) effects of hGH without its growth-promoting or diabetogenic side effects. It is often referred to as the “fat-burning peptide” due to its ability to stimulate lipolysis (breakdown of fat) and inhibit lipogenesis (formation of new fat), thereby promoting targeted fat loss—particularly in stubborn areas like the abdomen—while preserving muscle mass.
Key Benefits and Mechanism
-
Fat Metabolism: AOD 9604 enhances fat oxidation and reduces body fat accumulation by directly targeting adipose tissue.
-
Metabolic Support: It accelerates metabolism and supports healthy weight loss without increasing appetite or affecting blood glucose levels.
-
Joint and Bone Health: Emerging research suggests potential benefits in cartilage repair and bone strength, possibly aiding in conditions like osteoarthritis and osteoporosis. Mechanism: Unlike full-length hGH, AOD 9604 does not activate the growth hormone receptor, minimizing systemic hormonal disruptions.
Safety and Side Effects
-
Generally Well-Tolerated: Clinical trials indicate good short-term tolerability with no significant impact on insulin sensitivity, glucose levels, or IGF-1 levels.
-
Common Side Effects: Reported side effects include nausea, headaches, fatigue, and mild injection site irritation.
-
Long-Term Safety: Unknown; no long-term human safety data is available.
Regulatory Status and Availability
-
Not FDA-Approved: AOD 9604 is not approved by the FDA for any medical use in the U.S.
-
Research Chemical: It is classified as a research peptide and sold online for non-clinical use (e.g., injectable, oral, sublingual forms), but quality and regulation vary widely.
Reviews
There are no reviews yet.